We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+54.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.2B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
195
New
Increased
Reduced
Closed

Top Buys

1 +$203M
2 +$156M
3 +$146M
4
AMGN icon
Amgen
AMGN
+$98.7M
5
VRDN icon
Viridian Therapeutics
VRDN
+$70.3M

Top Sells

1 +$350M
2 +$235M
3 +$225M
4
RNAM
Avidity Biosciences
RNAM
+$190M
5
FOLD
Amicus Therapeutics
FOLD
+$153M

Sector Composition

1 Healthcare 99.74%
2 Energy 0.07%
3 Technology 0.06%
4 Financials 0.03%
5 Consumer Discretionary 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBNX
101
Beta Bionics
BBNX
$750M
$723K 0.02%
72,152
-133
BIIB icon
102
Biogen
BIIB
$31.9B
$670K 0.02%
3,653
+88
LEGN icon
103
Legend Biotech
LEGN
$5.55B
$649K 0.02%
35,886
-28,085
CSCO icon
104
Cisco
CSCO
$448B
$621K 0.01%
8,000
NBIX icon
105
Neurocrine Biosciences
NBIX
$16.9B
$612K 0.01%
4,646
-1,698,658
BABA icon
106
Alibaba
BABA
$228B
$590K 0.01%
4,700
CYTK icon
107
Cytokinetics
CYTK
$11.2B
$583K 0.01%
8,841
-384
CERT icon
108
Certara
CERT
$908M
$567K 0.01%
99,442
PRAX icon
109
Praxis Precision Medicines
PRAX
$9.14B
$566K 0.01%
+1,757
PG icon
110
Procter & Gamble
PG
$347B
$563K 0.01%
3,900
MA icon
111
Mastercard
MA
$441B
$550K 0.01%
1,100
COR icon
112
Cencora
COR
$55.7B
$539K 0.01%
1,716
+1,195
AXSM icon
113
Axsome Therapeutics
AXSM
$12.4B
$538K 0.01%
3,181
-24,419
GDX icon
114
VanEck Gold Miners ETF
GDX
$23.5B
$528K 0.01%
5,750
-9,750
AGMB
115
AgomAb Therapeutics NV
AGMB
$680M
$525K 0.01%
+50,000
BLK icon
116
Blackrock
BLK
$150B
$433K 0.01%
450
V icon
117
Visa
V
$639B
$423K 0.01%
1,400
CNTA
118
DELISTED
Centessa Pharmaceuticals
CNTA
$359K 0.01%
+9,030
DNLI icon
119
Denali Therapeutics
DNLI
$4.06B
$341K 0.01%
17,766
+10,628
GPCR icon
120
Structure Therapeutics
GPCR
$3.53B
$328K 0.01%
6,803
-138,364
JD icon
121
JD.com
JD
$34.3B
$325K 0.01%
11,000
ALKS icon
122
Alkermes
ALKS
$9.18B
$314K 0.01%
8,870
+2,276
GRMN
123
DELISTED
Garmin
GRMN
$306K 0.01%
1,321
-405
SMMT icon
124
Summit Therapeutics
SMMT
$10.9B
$301K 0.01%
15,858
+1,596
ACN icon
125
Accenture
ACN
$78.9B
$297K 0.01%
1,500